-   Training & Support

[Expand/Collapse all sections]Expand all

Eye programs restriction and item codes

Do not share these attachments externally. See Freedom of Information –
Information Publication Scheme.
[\\INTERNAL.DEPT.LOCAL\Shared\NAT\SERDELEXCEL\WORKPRODIMP\Operation
Blueprint Migration\RDT Release Icons\32w\icon-hidden-attachment.png]PBS
subfoveal choroidal neovascularisation restriction and item codes
[\\INTERNAL.DEPT.LOCAL\Shared\NAT\SERDELEXCEL\WORKPRODIMP\Operation
Blueprint Migration\RDT Release
Icons\32w\icon-hidden-attachment.png]Diabetic macular oedema and retinal
vein occlusion restriction and item codes

Contact details

PBS Complex Drugs Programs team

Forms

Subfoveal choroidal neovascularisation - initial authority application
(PB072)

Diabetic macular oedema - initial authority application (PB155)

Retinal vein occlusion - initial authority application (PB154)

Subfoveal choroidal neovascularisation – faricimab – initial grandfather
authority application form (PB347)

Diabetic macular oedema – faricimab – initial grandfather authority
application form (PB346)

Services Australia website

Subfoveal choroidal neovascularisation (CNV)

Diabetic macular oedema (DMO)

Retinal vein occlusion (RVO)

External websites

PBS schedule for Complex Eye Programs drugs

Frequently asked questions

+-----------------------------------+-----------------------------------+
| Item                              | Question and answer               |
+-----------------------------------+-----------------------------------+
| 1                                 | Question: An application was      |
|                                   | approved yesterday, can the       |
|                                   | prescriber self-serve a           |
|                                   | continuing script today?          |
|                                   |                                   |
|                                   | Answer: Yes, there is no 'too     |
|                                   | soon' rule for the Eye Program.   |
+-----------------------------------+-----------------------------------+
| 2                                 | Question: Can I approve 2         |
|                                   | prescriptions for the same drug   |
|                                   | and condition on the same day?    |
|                                   |                                   |
|                                   | Answer: No, same day prescribing  |
|                                   | rule applies.                     |
+-----------------------------------+-----------------------------------+
| 3                                 | Question: If I receive a          |
|                                   | prescription stating 'initial     |
|                                   | treatment' but no application     |
|                                   | form has been submitted, what do  |
|                                   | I do?                             |
|                                   |                                   |
|                                   | Answer: Reject the application,   |
|                                   | an authority application form     |
|                                   | must be submitted for an initial  |
|                                   | authority request.                |
+-----------------------------------+-----------------------------------+
| 4                                 | Question: If a prescription       |
|                                   | states multiple conditions, what  |
|                                   | do I do?                          |
|                                   |                                   |
|                                   | Answer: Reject as the prescriber  |
|                                   | must state the condition they are |
|                                   | requesting authority approval     |
|                                   | for.                              |
+-----------------------------------+-----------------------------------+
| 5                                 | Question: If the prescription     |
|                                   | states both eyes and the quantity |
|                                   | is only '1', what do I do?        |
|                                   |                                   |
|                                   | Answer: Approve the prescription  |
|                                   | as quantity '1'. Complete OPA Q&A |
|                                   | as 'both eyes'.                   |
+-----------------------------------+-----------------------------------+
| 6                                 | Question: What do I do if I       |
|                                   | receive an Eylea® prescription    |
|                                   | for a 2mg strength?               |
|                                   |                                   |
|                                   | Answer: Approve, 2 mg is the      |
|                                   | actual dose given to the patient. |
+-----------------------------------+-----------------------------------+
| 7                                 | Question: A prescription states   |
|                                   | the following abbreviations OU,   |
|                                   | OS or OD. How do I proceed?       |
|                                   |                                   |
|                                   | Answer:                           |
|                                   |                                   |
|                                   | -   OU (Oculus uterque) is both   |
|                                   |     eyes                          |
|                                   | -   OS (Oculus sinister) is left  |
|                                   |     eye                           |
|                                   | -   OD (oculus dextrus) is right  |
|                                   |     eye                           |
+-----------------------------------+-----------------------------------+
| 8                                 | Question: If I get the same       |
|                                   | request twice in HPOS, do I need  |
|                                   | to respond?                       |
|                                   |                                   |
|                                   | Answer: Reply to the first        |
|                                   | request. A second response is not |
|                                   | required.                         |
+-----------------------------------+-----------------------------------+
| 9                                 | Question: Can I approve increased |
|                                   | repeats?                          |
|                                   |                                   |
|                                   | Answer: No, maximum repeats are   |
|                                   | on the item code sheets.          |
+-----------------------------------+-----------------------------------+
| 10                                | Question: The prescriber has      |
|                                   | written 'diabetic retinopathy',   |
|                                   | can I accept this as DMO?         |
|                                   |                                   |
|                                   | Answer: No, this is a different   |
|                                   | condition from DMO.               |
+-----------------------------------+-----------------------------------+
| 11                                | Question: The prescriber has      |
|                                   | written 'diabetic maculopathy',   |
|                                   | can I accept this as DMO?         |
|                                   |                                   |
|                                   | Answer: No, this can be caused by |
|                                   | DMO. However, the prescriber must |
|                                   | confirm that the patient has DMO. |
+-----------------------------------+-----------------------------------+
| 12                                | Question: I am processing several |
|                                   | applications from different       |
|                                   | prescribers located at the same   |
|                                   | clinic, can I post them all back  |
|                                   | in the one envelope?              |
|                                   |                                   |
|                                   | Answer: No, Service Officers must |
|                                   | send each prescriber’s            |
|                                   | applications separately.          |
|                                   |                                   |
|                                   | Where surgeries include a return  |
|                                   | express post envelope for         |
|                                   | multiple prescribers, create      |
|                                   | individual envelopes for each     |
|                                   | prescriber. Return the sealed     |
|                                   | envelopes in the same express     |
|                                   | post envelope.                    |
+-----------------------------------+-----------------------------------+
| 13                                | Question: I have received a       |
|                                   | prescription for brolucizumab     |
|                                   | (Beovu®) with a strength of       |
|                                   | 120mg/mL, what do I do?           |
|                                   |                                   |
|                                   | Answer: Approve the prescription; |
|                                   | 120mg/mL is another way to write  |
|                                   | 6mg/0.05mL.                       |
+-----------------------------------+-----------------------------------+
| 14                                | Question: I have received a       |
|                                   | prescription for faricimab        |
|                                   | (Vabysmo) with a strength of      |
|                                   | 120mg/mL, what do I do?           |
|                                   |                                   |
|                                   | Answer: Approve the prescription; |
|                                   | 120mg/mL is another way to write  |
|                                   | 28.8 mg/0.24 mL.                  |
+-----------------------------------+-----------------------------------+
| 15                                | Question: I have received a       |
|                                   | prescription for faricimab        |
|                                   | (Vabysmo) with a strength of      |
|                                   | 6mg/0.05mL, what do I do?         |
|                                   |                                   |
|                                   | Answer: Approve the prescription; |
|                                   | 6mg/0.05mL is another way to      |
|                                   | write 28.8 mg/0.24mL.             |
+-----------------------------------+-----------------------------------+
| 16                                | Question: Does the initial form   |
|                                   | have to include the unique        |
|                                   | identifier or provider number,    |
|                                   | and the date of report?           |
|                                   |                                   |
|                                   | Answer: Yes, these details need   |
|                                   | to be completed to address the    |
|                                   | Q&A.                              |
+-----------------------------------+-----------------------------------+
| 17                                | Question: The prescriber submits  |
|                                   | a request for continuing          |
|                                   | treatment for aflibercept         |
|                                   | (Eylea®) for a quantity of 1. How |
|                                   | do I action?                      |
|                                   |                                   |
|                                   | Answer: Return to the prescriber. |
|                                   | Generate a rejection letter, and  |
|                                   | select the ‘streamlined           |
|                                   | authority’ option.                |
+-----------------------------------+-----------------------------------+
| 18                                | Question: The prescriber requests |
|                                   | an approval for a quantity of 2   |
|                                   | for ranibizumab (Lucentis®) over  |
|                                   | the phone, how do I action?       |
|                                   |                                   |
|                                   | Answer: Issue an approval with    |
|                                   | the prescriber. Remind the        |
|                                   | prescriber that they can          |
|                                   | self-serve electronically. Due to |
|                                   | the increase quantity, it isn’t   |
|                                   | available as a streamlined item.  |
+-----------------------------------+-----------------------------------+

                                   

-   Services Australia ABN 90 794 605 008 
